Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07083856

Effects of Reiki and Self-Acupressure Applications

Reiki, the subject of our research, is a complementary medicine practice within energy approaches. Discovered in Sanskrit texts by Dr. Usui in Japan in the late 19th century, it was demonstrated through studies demonstrating its effectiveness in symptoms of pain, depression, insomnia, and fatigue. Everything in the universe, including the human body, is composed of energy; any disruption in this energy can lead to illness. There are seven chakras where Reiki is applied. The main chakra centers are located along the spine. During Reiki treatments, the hands are held in each position, touching the head, neck, chest, abdominal cavity, and groin for 3-5 minutes. This period may extend to 10-20 minutes in problematic areas. The average treatment duration is 30-90 minutes. During the treatment, the patient lies down or reclines, and there is no need to remove clothing. During Reiki treatment, individuals may report a slight warming sensation under or near the therapist's hand. The only rule in Reiki practice is that the individual gives the practitioner permission to facilitate the flow of energy. The person receiving Reiki does not need to believe in Reiki during the treatment. Reiki is a universal life energy present in everyone. Reiki is generally safe, and no serious side effects have been reported. Over the last 10 years, Reiki practice has been increasing among physicians, nurses, and other healthcare professionals. This study will compare the effects of acupressure and Reiki treatments on functionality and quality of life in patients with multiple sclerosis.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Multiple Sclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Immune System Diseases Nervous System Diseases

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Muğla Sıtkı Koçman University

Muğla, Fethi̇ye, 48300, Turkey (Türkiye)

Location status: Recruiting

Location contact

Furkan Bilek

CONTACT

[email protected]

05442772249

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are willing to participate
  • Patients who have no communication problems
  • Patients who are 18 years of age or older
  • Patients who live in the center
  • Patients who have no scratches or deformities in the treatment area
  • Patients who do not smoke, use drugs, or use tranquilizers, and are not pregnant
  • Patients who have been receiving MS treatment for more than three months

Exclusion criteria

  • Patients who smoke, use substances, or use tranquilizers
  • Have dyspnea
  • Have anemia
  • Have diabetes
  • Have received corticosteroid treatment in the last three months
  • Have had an MS attack in the last three months
  • Have an autoimmune disease other than multiple sclerosis
  • Have signs of infection
  • Have a thyroid problem
  • Are taking psychostimulant medications
  • Have anxiety or depression detected in outpatient clinic screenings
  • Refuse to participate in the study
  • Have another known neurological system disease (dementia, Alzheimer's, etc.)
  • Have a communication barrier will not be included in the study.

Treatment and study plan

Reiki

Behavioral

Reiki

Self-acupressure

Behavioral

Self-Acupressure

Primary outcomes

  1. The Multiple Sclerosis Quality of Life

    Time frame: 4 weeks

    The Turkish adaptation of the scale was conducted by Tülek in 2006. Tülek found Cronbach's alpha reliability coefficients to be 0.94 for the composite physical health and 0.89 for the composite mental health. This scale was created by adding 18 items related to MS-specific problems to the items related to general health perception (5 items), energy/fatigue (5 items), social functioning (2 items), emotional well-being (5 items), role limitations due to emotional problems (3 items), physical functioning (10 functions), role limitations due to physical problems (4 items), pain (3 items), and health changes found in the SF-36, a widely used generic quality of life scale for many conditions. The MSQOL-54 Quality of Life Scale consists of two main groups: physical health composite and mental health composite, 13 subgroups, and two independent items. Scores range from 0 to 100, with higher scores indicating higher quality of life.

  2. The Multiple Sclerosis Functional Composite

    Time frame: 4 weeks

    The Scale consists of three subtests: the "9-Hole Peg Test" that evaluates upper extremity functions, the "25-Step Walking Test" that checks lower extremity functions, and the "Step Auditory Serial Addition Test" that evaluates immediate memory and cognitive functions. It was administered within the MSFC.

Study contacts

Contact information is provided by the study sponsor or research team.

Furkan Bilek

CONTACT

[email protected]

05442772249

Furkan Bilek, PhD

CONTACT

[email protected]

+905442772249

Sponsors and collaborators

Lead sponsor

Firat University

Other

Registry information

Official study title

Comparison of the Effects of Reiki and Self-Acupressure Applications on Functionality and Quality of Life in Patients With Multiple Sclerosis: A Randomized Controlled Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Jul 24, 2025
Registry last updated
Jul 24, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.